|
|
Product trade name: Bezalip Retard
| Pharmaceutical active ingredients: |
| Bezafibrate |
| Available forms, composition and doses of Bezalip Retard: |
| Tablets, Extended Release; Oral; Bezafibrate 400 mg |
| Bezalip Retard medical category: |
| Human:Dyslipidaemic agentsFribic Acid derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C10AB02 - Bezafibrate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheActavisDKSHFirma Chun CheongZuellig Pharma |
Pharmaceutical drugs, medications and other health products with similar to Bezalip Retard trade names:
Compare some medical and health care products with the same or related to Bezalip Retard active ingredients:
More pharmaceutical products manufactured or supplied by the same as Bezalip Retard and similar pharmaceutical companies:
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Betiral | Ornidazole | Roche | | Betriple | Intrinsic Factor; Vitamin B1 (Thiamine Nitrate); Vitamin B12 (Cyanocobalamin); Vitamin B6 (Pyridoxine Hydrochloride) | Roche | | Bex | Aspirin | Roche | | Bezalip | Bezafibrate | Roche; Actavis; Firma Chun Cheong; Nicholas Piramal; R.X. Company; Teva; Zuellig Pharma | | Bezalip Mono | Bezafibrate | Roche | | Bezalip SR | Bezafibrate | Roche; Actavis | | Bi-Euglucon M | Glyburide; Metformin Hydrochloride | Roche | | Bi-Euglucon, Italy | Glyburide; Phenformin Hydrochloride | Roche | | Bi-Euglucon, Venezuela | Glyburide; Metformin Hydrochloride | Roche | | Bifix | Nifuroxazide | Roche |
|
|